DocGo Inc. (NASDAQ:DCGO) Stock Holdings Lessened by Arena Capital Advisors LLC CA

Arena Capital Advisors LLC CA lessened its stake in DocGo Inc. (NASDAQ:DCGO) by 25.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 29,870 shares of the company’s stock after selling 10,000 shares during the quarter. DocGo makes up about 0.2% of Arena Capital Advisors LLC CA’s portfolio, making the stock its 8th biggest holding. Arena Capital Advisors LLC CA’s holdings in DocGo were worth $127,000 as of its most recent filing with the SEC.

A number of other large investors also recently added to or reduced their stakes in DCGO. SG Americas Securities LLC boosted its stake in shares of DocGo by 12.9% in the fourth quarter. SG Americas Securities LLC now owns 43,052 shares of the company’s stock worth $183,000 after acquiring an additional 4,905 shares during the last quarter. Rhumbline Advisers lifted its holdings in DocGo by 4.5% in the 4th quarter. Rhumbline Advisers now owns 142,762 shares of the company’s stock valued at $605,000 after purchasing an additional 6,204 shares in the last quarter. Victory Capital Management Inc. boosted its stake in DocGo by 12.3% during the 4th quarter. Victory Capital Management Inc. now owns 57,649 shares of the company’s stock worth $244,000 after purchasing an additional 6,300 shares during the last quarter. Centiva Capital LP purchased a new stake in shares of DocGo during the third quarter worth $43,000. Finally, Royce & Associates LP purchased a new stake in shares of DocGo during the fourth quarter worth $64,000. 56.44% of the stock is currently owned by institutional investors and hedge funds.

DocGo Trading Down 0.7 %

DocGo stock opened at $2.85 on Friday. The company has a 50-day moving average price of $4.31 and a 200 day moving average price of $3.98. DocGo Inc. has a 12-month low of $2.75 and a 12-month high of $5.68. The stock has a market cap of $290.65 million, a P/E ratio of 10.18, a PEG ratio of 14.16 and a beta of 1.08.

Analyst Ratings Changes

Several equities analysts have recently weighed in on DCGO shares. Stifel Nicolaus decreased their price target on shares of DocGo from $6.50 to $5.50 and set a “buy” rating on the stock in a research note on Friday, February 28th. Needham & Company LLC decreased their target price on shares of DocGo from $7.00 to $4.00 and set a “buy” rating on the stock in a research note on Friday, February 28th. Finally, Deutsche Bank Aktiengesellschaft lowered DocGo from a “buy” rating to a “hold” rating and dropped their price target for the company from $5.00 to $2.85 in a research report on Friday, February 28th. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $4.89.

Insider Activity

In other news, General Counsel Ely D. Tendler sold 23,088 shares of DocGo stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $4.44, for a total transaction of $102,510.72. Following the sale, the general counsel now owns 175,645 shares of the company’s stock, valued at approximately $779,863.80. The trade was a 11.62 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 2.70% of the company’s stock.

DocGo Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.